Pasticier G, Timsit M-O, Badet L, De La Torre Abril L, Halila M, Fassi Fehri H, Colombel M, Martin X
Department of Urology and Transplantation, Edouard Herriot Hospital, University of Lyon, France.
Eur Urol. 2006 Mar;49(3):485-90. doi: 10.1016/j.eururo.2005.12.049. Epub 2006 Jan 11.
To assess the incidence of complications of conservative renal surgery for renal cell carcinoma in both elective and imperative indications, and its evolution over a 15 year period.
From 1988 to 2003, 127 patients underwent partial nephrectomy or tumorectomy for renal cell carcinoma in our department. INDICATIONs were imperative in 42% (n = 53) and elective in 58% (n=74) of cases. Morbidity was retrospectively assessed according to four parameters: 1- Period of surgery: A, from 1988 to 1999 and B, from 2000 to 2003. 2- INDICATION: elective vs. imperative. 3- experience of surgeon: senior vs. junior. 4- Nature of complications: minor or major. Comparative analysis was conducted using Chi-square and Fischer exact tests.
Global incidence of complications was 30.7% (n = 39) corresponding to 18.1% minor (n = 23) and 12.6% (n = 16) major complications. Results show a moderate decrease of complication rate during Period B: 28.1% versus 32.9% during period A (p = 0.69). Complications occurred more frequently in imperative indications (49.1%) than in elective indications (17.6%) (p = 0.002), mostly regarding major complications (respectively 28.3% and 1.4%. (p < 0.001)). Overall re-intervention rate was 15.7%: 22.6% in imperative and 10.8% in elective indications (p = 0.008). Mean length of hospital stay was 14.1 days and significantly longer during period A (p = 0.003) and in imperative indications (p = 0.009).
In our study, conservative renal surgery has a significant rate of complications which is extremely variable regarding to different parameters. Most discriminating factor was indication: in imperative indications, we observed a high rate of major complications (28.3%) that we consider acceptable to prevent anephria in clearly informed patients. Major complications are exceptional in elective indications. Decreased incidence of complications during the later period (B) is modest, and the role played by systematic pedicular clampage is discussed. As results published in medical literature are difficult to compare, we agree with authors who recently proposed to standardize complications data analysis, using a gravity scale, in order to provide relevant information to patients about statistical risks before surgery.
评估在选择性和必要性适应症下,肾细胞癌保守性肾手术并发症的发生率及其在15年期间的变化情况。
1988年至2003年,我科127例患者因肾细胞癌接受了部分肾切除术或肿瘤切除术。42%(n = 53)的病例为必要性适应症,58%(n = 74)为选择性适应症。根据四个参数对发病率进行回顾性评估:1 - 手术时期:A,1988年至1999年;B,2000年至2003年。2 - 适应症:选择性与必要性。3 - 外科医生经验:资深与初级。4 - 并发症性质:轻微或严重。采用卡方检验和费舍尔精确检验进行比较分析。
并发症的总体发生率为30.7%(n = 39),其中轻微并发症占18.1%(n = 23),严重并发症占12.6%(n = 16)。结果显示,B期并发症发生率有适度下降:B期为28.1%,A期为32.9%(p = 0.69)。必要性适应症的并发症发生率(49.1%)高于选择性适应症(17.6%)(p = 0.002),主要是严重并发症(分别为28.3%和1.4%,p < 0.001)。总体再次干预率为15.7%:必要性适应症为22.6%,选择性适应症为10.8%(p = 0.008)。平均住院时间为14.1天,A期明显更长(p = 0.003),必要性适应症也更长(p = 0.009)。
在我们的研究中,保守性肾手术有显著的并发症发生率,且因不同参数而有极大差异。最具区分性的因素是适应症:在必要性适应症中,我们观察到严重并发症发生率较高(28.3%),我们认为在充分告知患者的情况下,为预防无肾状态,这一发生率是可接受的。在选择性适应症中,严重并发症很罕见。后期(B期)并发症发生率的下降幅度不大,并讨论了系统性肾蒂钳夹术所起的作用。由于医学文献中发表的结果难以比较,我们赞同近期一些作者的提议,即使用严重程度量表对并发症数据分析进行标准化,以便在手术前向患者提供有关统计风险的相关信息。